162 related articles for article (PubMed ID: 38364250)
1. Identification of hypoxic-related lncRNAs prognostic model for revealing clinical prognostic and immune infiltration characteristic of cutaneous melanoma.
Liao C; Yang J; Chen L; Ye Z
Aging (Albany NY); 2024 Feb; 16(4):3734-3749. PubMed ID: 38364250
[TBL] [Abstract][Full Text] [Related]
2. The development and experimental validation of hypoxia-related long noncoding RNAs prognostic signature in predicting prognosis and immunotherapy of cutaneous melanoma.
Wang G; Sun Y; Xu Q
Aging (Albany NY); 2023 Nov; 15(21):11918-11939. PubMed ID: 37921852
[TBL] [Abstract][Full Text] [Related]
3. Machine learning-based signature of necrosis-associated lncRNAs for prognostic and immunotherapy response prediction in cutaneous melanoma and tumor immune landscape characterization.
Cui Z; Liang Z; Song B; Zhu Y; Chen G; Gu Y; Liang B; Ma J; Song B
Front Endocrinol (Lausanne); 2023; 14():1180732. PubMed ID: 37229449
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma.
Guo S; Chen J; Yi X; Lu Z; Guo W
Front Immunol; 2022; 13():985051. PubMed ID: 36248853
[TBL] [Abstract][Full Text] [Related]
6. Explore the impact of hypoxia-related genes (HRGs) in Cutaneous melanoma.
Ke G; Cheng N; Sun H; Meng X; Xu L
BMC Med Genomics; 2023 Jul; 16(1):160. PubMed ID: 37422626
[TBL] [Abstract][Full Text] [Related]
7. A novel RNA sequencing-based prognostic nomogram to predict survival for patients with cutaneous melanoma: Clinical trial/experimental study.
Tian J; Yang Y; Li MY; Zhang Y
Medicine (Baltimore); 2020 Jan; 99(3):e18868. PubMed ID: 32011509
[TBL] [Abstract][Full Text] [Related]
8. Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.
Lin J; Lin Y; Huang Z; Li X
Comput Math Methods Med; 2020; 2020():8836493. PubMed ID: 33273963
[TBL] [Abstract][Full Text] [Related]
9. Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma.
Lin W; Tan ZY; Fang XC
SLAS Technol; 2024 Feb; 29(1):100101. PubMed ID: 37541541
[TBL] [Abstract][Full Text] [Related]
10. Necroptosis-related LncRNAs in skin cutaneous melanoma: evaluating prognosis, predicting immunity, and guiding therapy.
Liu J; Luo B; Zhang P; Jiang K; Hou Z; Cao X; Tang J
BMC Cancer; 2023 Aug; 23(1):752. PubMed ID: 37580654
[TBL] [Abstract][Full Text] [Related]
11. Development of anoikis-related long non-coding RNA signature associated with prognosis and immune landscape in cutaneous melanoma patients.
Zhong L; Qian W; Gong W; Zhu L; Zhu J
Aging (Albany NY); 2023 Aug; 15(15):7655-7672. PubMed ID: 37543428
[TBL] [Abstract][Full Text] [Related]
12. A novel endoplasmic reticulum stress-related lncRNA prognostic risk model for cutaneous melanoma.
Li AA; Li F; Lan M; Zhang Y; Xie D; Yan MY
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3227-3241. PubMed ID: 35687183
[TBL] [Abstract][Full Text] [Related]
13. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
Wu L; Liu G; He YW; Chen R; Wu ZY
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Novel Hypoxia-Related Long Noncoding RNA Model With Regard to Prognosis and Immune Features in Breast Cancer.
Gu P; Zhang L; Wang R; Ding W; Wang W; Liu Y; Wang W; Li Z; Yan B; Sun X
Front Cell Dev Biol; 2021; 9():796729. PubMed ID: 34977036
[No Abstract] [Full Text] [Related]
15. Pyroptosis-related lncRNA prognostic signatures for cutaneous melanoma and tumor microenvironment status.
Deng H; Chen Y; An R; Wang J
Epigenomics; 2023 Jun; 15(12):657-675. PubMed ID: 37577979
[No Abstract] [Full Text] [Related]
16. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of immune-related lncRNA prognostic signatures for melanoma.
Xiao B; Liu L; Li A; Wang P; Xiang C; Li H; Xiao T
Immun Inflamm Dis; 2021 Sep; 9(3):1044-1054. PubMed ID: 34077998
[TBL] [Abstract][Full Text] [Related]
18. Prognostic signature construction and immunotherapy response analysis for Uterine Corpus Endometrial Carcinoma based on cuproptosis-related lncRNAs.
Zhang X; Ye Z; Xiao G; He T
Comput Biol Med; 2023 Jun; 159():106905. PubMed ID: 37060773
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma.
Xu S; Tang L; Liu Z; Luo C; Cheng Q
Front Immunol; 2021; 12():731048. PubMed ID: 34659218
[TBL] [Abstract][Full Text] [Related]
20. Molecular Subtypes Based on PANoptosis Genes and Characteristics of Immune Infiltration in Cutaneous Melanoma.
Zhong L; Qian W; Gong W; Zhu L; Wang X
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):1-8. PubMed ID: 37715443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]